chr14-55138320-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000254301.14(LGALS3):c.294C>T(p.Thr98Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00177 in 1,612,398 control chromosomes in the GnomAD database, including 57 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0092 ( 31 hom., cov: 33)
Exomes 𝑓: 0.00099 ( 26 hom. )
Consequence
LGALS3
ENST00000254301.14 synonymous
ENST00000254301.14 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.905
Genes affected
LGALS3 (HGNC:6563): (galectin 3) This gene encodes a member of the galectin family of carbohydrate binding proteins. Members of this protein family have an affinity for beta-galactosides. The encoded protein is characterized by an N-terminal proline-rich tandem repeat domain and a single C-terminal carbohydrate recognition domain. This protein can self-associate through the N-terminal domain allowing it to bind to multivalent saccharide ligands. This protein localizes to the extracellular matrix, the cytoplasm and the nucleus. This protein plays a role in numerous cellular functions including apoptosis, innate immunity, cell adhesion and T-cell regulation. The protein exhibits antimicrobial activity against bacteria and fungi. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 14-55138320-C-T is Benign according to our data. Variant chr14-55138320-C-T is described in ClinVar as [Benign]. Clinvar id is 776843.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.905 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00924 (1408/152302) while in subpopulation AFR AF= 0.0326 (1353/41558). AF 95% confidence interval is 0.0311. There are 31 homozygotes in gnomad4. There are 645 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 31 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LGALS3 | NM_002306.4 | c.294C>T | p.Thr98Thr | synonymous_variant | 3/6 | ENST00000254301.14 | NP_002297.2 | |
LGALS3 | NM_001357678.2 | c.336C>T | p.Thr112Thr | synonymous_variant | 4/7 | NP_001344607.1 | ||
LGALS3 | NR_003225.2 | n.1338C>T | non_coding_transcript_exon_variant | 1/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LGALS3 | ENST00000254301.14 | c.294C>T | p.Thr98Thr | synonymous_variant | 3/6 | 1 | NM_002306.4 | ENSP00000254301.9 |
Frequencies
GnomAD3 genomes AF: 0.00923 AC: 1405AN: 152184Hom.: 31 Cov.: 33
GnomAD3 genomes
AF:
AC:
1405
AN:
152184
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00218 AC: 529AN: 242294Hom.: 7 AF XY: 0.00156 AC XY: 207AN XY: 133066
GnomAD3 exomes
AF:
AC:
529
AN:
242294
Hom.:
AF XY:
AC XY:
207
AN XY:
133066
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000987 AC: 1441AN: 1460096Hom.: 26 Cov.: 33 AF XY: 0.000807 AC XY: 586AN XY: 726402
GnomAD4 exome
AF:
AC:
1441
AN:
1460096
Hom.:
Cov.:
33
AF XY:
AC XY:
586
AN XY:
726402
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00924 AC: 1408AN: 152302Hom.: 31 Cov.: 33 AF XY: 0.00866 AC XY: 645AN XY: 74482
GnomAD4 genome
AF:
AC:
1408
AN:
152302
Hom.:
Cov.:
33
AF XY:
AC XY:
645
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 05, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at